My interest was aroused by the statement that the Company would expand into broader Med Tech areas including collaborations and product based acquisitions. I can understand collaborations in relation to the vaccine programs but I don't have a clue on what we may be considering in product based acquisitions. Does anyone have any idea?
AGM (10/11/16), page-87
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M | |||
| Open | High | Low | Value | Volume |
| $18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 554 | 1 |
View Market Depth
| Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |